Literature DB >> 7850414

Physiologic and pathophysiologic roles of endothelin in the kidney.

A L Clavell1, J C Burnett.   

Abstract

Endothelin is an important modulator of renal function via its binding to abundant receptors in renal tissue and by the ability of renal endothelial and epithelial cells to synthesize and release endothelin. In the kidney, endothelin may function as a paracrine-autocrine factor in the regulation of renal blood flow, glomerular hemodynamics, and sodium and water homeostasis. Recent evidence suggests that circulating endothelin may play an important role in renal regulation in cardiorenal states of endothelin activation. Endothelin is a potent renal vasconstrictor that has dual actions on glomerular filtration rate due to its ability to preferentially constrict efferent arterioles preserving glomerular filtration. Furthermore, endothelin modulates sodium excretion and water balance at the level of the proximal tubule and medullary collecting ducts, respectively, by mechanisms that are still unclear. In addition, endothelin stimulates the renin-angiotensin-aldosterone system and atrial natriuretic peptide release and inhibits arginine vasopressin-mediated water reabsorption in the inner medullary collecting duct. Recent studies using specific receptor antagonists have demonstrated a pathophysiologic role for endothelin during renal ischemia, cyclosporine-induced toxicity, and chronic renal failure. This review highlights recent research that supports an important role for endothelin as a locally produced vasoactive and natriuretic peptide in the regulation of renal hemodynamic and excretory functions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7850414     DOI: 10.1097/00041552-199401000-00010

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  7 in total

Review 1.  The future of endothelin-receptor antagonism as treatment for systemic hypertension.

Authors:  Gabriel Vorobiof; Burns C Blaxall; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

2.  Delivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in rats.

Authors:  Ling Tu; Xizhen Xu; Huaibing Wan; Changqing Zhou; Juanjuan Deng; Gang Xu; Xiao Xiao; Yipu Chen; Matthew L Edin; James W Voltz; Darryl C Zeldin; Dao Wen Wang
Journal:  Hum Gene Ther       Date:  2008-04       Impact factor: 5.695

Review 3.  Role of vasopressin antagonists in the management of acute decompensated heart failure.

Authors:  Cesare Orlandi; Christopher A Zimmer; Mihai Gheorghiade
Journal:  Curr Heart Fail Rep       Date:  2005-09

4.  The effect of bosentan on the pharmacokinetics of digoxin in healthy male subjects.

Authors:  C Weber; L Banken; H Birnboeck; S Nave; R Schulz
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 5.  Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy.

Authors:  Zaid Abassi; Ilia Goltsman; Tony Karram; Joseph Winaver; Aaron Hoffman
Journal:  J Biomed Biotechnol       Date:  2011-01-11

6.  The Role of Endothelins, IL-18, and NGAL in Kidney Hypothermic Machine Perfusion.

Authors:  Karol Tejchman; Adam Nowacki; Katarzyna Kotfis; Edyta Skwirczynska; Maciej Kotowski; Labib Zair; Marek Ostrowski; Jerzy Sienko
Journal:  Biomedicines       Date:  2021-04-13

7.  Preoperative Serum GDF-15, Endothelin-1 Levels, and Intraoperative Factors as Short-Term Operative Risks for Patients Undergoing Cardiovascular Surgery.

Authors:  Takashi Kato; Toshiaki Nakajima; Taira Fukuda; Ikuko Shibasaki; Takaaki Hasegawa; Koji Ogata; Hironaga Ogawa; Shotaro Hirota; Hirotaka Ohashi; Shunsuke Saito; Yusuke Takei; Masahiro Tezuka; Masahiro Seki; Toshiyuki Kuwata; Masashi Sakuma; Shichiro Abe; Shigeru Toyoda; Teruo Inoue; Hirotsugu Fukuda
Journal:  J Clin Med       Date:  2021-05-02       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.